[
    [
        {
            "time": "",
            "original_text": "发生了什么？军工股突然大爆发，两只20%涨停",
            "features": {
                "keywords": [
                    "军工股",
                    "大爆发",
                    "涨停"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "军工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "发生了什么？军工股突然大爆发，两只20%涨停",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "另外，股价涨了这么多倍，一些股东、高管正在持续减持套现，这也会对公司股价形成一定打压。减持股份",
            "features": {
                "keywords": [
                    "股价",
                    "上涨",
                    "减持",
                    "套现",
                    "打压"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "另外，股价涨了这么多倍，一些股东、高管正在持续减持套现，这也会对公司股价形成一定打压。减持股份",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫苗股走软，智飞生物、长春高新、康泰生物、复星医药、华兰生物、万泰生物普跌",
            "features": {
                "keywords": [
                    "疫苗股",
                    "走软",
                    "普跌",
                    "智飞生物",
                    "长春高新",
                    "康泰生物",
                    "复星医药",
                    "华兰生物",
                    "万泰生物"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗股走软，智飞生物、长春高新、康泰生物、复星医药、华兰生物、万泰生物普跌",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物新冠灭活疫苗获临床试验批件，车间已完成建设",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠灭活疫苗",
                    "临床试验",
                    "批件",
                    "车间建设"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康泰生物新冠灭活疫苗获临床试验批件，车间已完成建设",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康泰生物(300601.SZ)：新型冠状病毒灭活疫苗(Vero细胞)获得临床试验批件",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新型冠状病毒灭活疫苗",
                    "Vero细胞",
                    "临床试验批件"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)：新型冠状病毒灭活疫苗(Vero细胞)获得临床试验批件",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：公司新型冠状病毒灭活疫苗（Vero细胞）获得临床试验批件",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新型冠状病毒灭活疫苗",
                    "Vero细胞",
                    "临床试验批件"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康泰生物：公司新型冠状病毒灭活疫苗（Vero细胞）获得临床试验批件",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]